The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells.

Saved in:
Bibliographic Details
Title: The histone deacetylase inhibitor ITF2357 has anti-leukemic activity in vitro and in vivo and inhibits IL-6 and VEGF production by stromal cells.
Authors: Golay, J.1, Cuppini, L.1, Leoni, F.2, Micò, C.1, Barbui, V.1, Domenghini, M.1, Lombardi, L.3, Neri, A.3, Barbui, A. M.1, Salvi, A.1, Pozzi, P.2, Porro, G.2, Pagani, P.2, Fossati, G.2, Mascagni, P.2, Introna, M.1, Rambaldi, A.1 arambaldi@ospedaliriuniti.bergamo.it
Source: Leukemia (08876924). Sep2007, Vol. 21 Issue 9, p1892-1900. 9p. 1 Chart, 7 Graphs.
Database: Academic Search Ultimate
Description
ISSN:08876924
DOI:10.1038/sj.leu.2404860